Alba Díaz

IRCCS Ospedale San Raffaele — Italy

Medicine · Health Sciences

33h-index4.8kcitations138works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Liver Disease Diagnosis and Treatment(44), Liver Disease and Transplantation(29), Hepatitis C virus research(17), Organ Transplantation Techniques and Outcomes(12), Liver Diseases and Immunity(12)

Publications135 total

Clinical course and prognostic risk factors of SARS-CoV-2 vaccine-related hepatitis: differentiating severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury from autoimmune hepatitis.
Open Access CRIS of the University of Bern·2026Open Access
Clinical course and prognostic risk factors of SARS-CoV-2 vaccine-related hepatitis: differentiating severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury from autoimmune hepatitis
European Journal of Gastroenterology & Hepatology·2026
BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update
Journal of Hepatology·2025· 25 cited
Expression of SREBF2 and HMGCR discriminates the viability of steatotic grafts for human liver transplantation
Journal of Lipid Research·2025Open Access
WITHDRAWN: 3P Engineered protein circuits directly rewire oncogenic Ras signalling to cell death
Annals of Oncology·2025
Molecular signatures discriminating different types of rejection in human liver transplants
Journal of Hepatology·2025· 3 citedOpen Access
Portosinusoidal Vascular Disorder: When to Suspect and How to Manage?
Seminars in Liver Disease·2025· 1 cited
Donor-derived cell-free DNA and miRNA monitoring for the early prediction and diagnosis of liver allograft rejection and patient outcomes
Frontiers in Immunology·2025· 1 citedOpen Access
An optimized peritonitis-induced ACLF model that reproduces the full spectrum of extrahepatic organ failures in mice
Hepatology Communications·2025Open Access
Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages
Frontiers in Immunology·2025· 2 citedOpen Access
Autoantibodies are associated with worse outcomes in MASLD
JHEP Reports·2025· 2 citedOpen Access
OS-029-YI Spatial profiling of HBVand HDV infection in human liver samples
Journal of Hepatology·2025
LBO-005 High prevalence of undiagnosed liver fibrosis in the adult european population driven by metabolic risk factors and alcohol consumption. results from the prospective liverscreen cohort in 30,541 subjects
Journal of Hepatology·2025· 2 cited
Diagnostic performance of contrast-enhanced US in small liver nodules not conclusively characterized after MRI in cirrhotic patients
European Radiology·2025· 2 cited
1421 Metallothionein 1 (MT-1) as a Histological Biomarker in Wilson’s Disease: Assessing its Diagnostic Utility
Laboratory Investigation·2025
Practices of low value or unnecessary practices in vascular prevention
Hipertensión y Riesgo Vascular·2025
Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer risk
BMC Gastroenterology·2025Open Access
Ex Vivo Fusion Confocal Microscopy of Liver Biopsies: Diagnostic Pattern Identification and Correlation with Conventional Microscopy
Applied Sciences·2024Open Access
Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome
Journal of Hepatology·2024· 37 citedOpen Access
Liver fibrosis screening increases alcohol abstinence
JHEP Reports·2024· 18 citedOpen Access
page 1 of 7Next →

Frequent Co-authors

María Reig(12), Pere Ginès(9), Llúcia Alós(9), Jordi Bruix(8), Isabel Graupera(8), Alejandro Forner(8), R. Vilana(7), Núria Fabrellas(7), Zoe Mariñó(6), Bruno Sangro(6), Xavier Forns(6), Llorenç Caballería(6), Juan Carlos García‐Pagán(6), Cristina Carrera(6), Susana Puig(6), Josep Malvehy(6), Sabela Lens(5), Anna Darnell(5), Marı́a Varela(5), José Luís Calleja(5)